United States · FDA National Drug Code directory
AMJEVITA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72511-481_1208dfda-344d-4919-b876-559e52119c8f
- Product NDC
- 72511-481
- Form
- INJECTION
- Composition / generic term
- adalimumab-atto
- Labeler
- Amgen USA Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20230814
- Source listing expiry
- 20271231
Source-listed ingredients
- ADALIMUMAB — 80 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (72511-481-02) / .8 mL in 1 SYRINGE · 72511-481-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →